CAR-T Cell Therapy Market Size, Share & Trends Analysis Report By Product (Abecma, Breyanzi, Kymriah, Tecartus, Yescarta, Others), By Indication (Leukemia, Lymphoma, Multiple Myeloma, Autoimmune Disorders, Others), By End User (Hospitals, Cancer Care Treatment Centres, Academic & Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
  7. North America CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
  8. Europe CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    7. France
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
  9. APAC CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
    5. China
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    8. India
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
  10. Middle East and Africa CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
  11. LATAM CAR-T Cell Therapy Market Size Analysis
    1. Introduction
    2. CAR-T Cell Therapy Market Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
      1. Abecma
      2. Breyanzi
      3. Kymriah
      4. Tecartus
      5. Yescarta
      6. Others
    3. CAR-T Cell Therapy Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Leukemia
      2. Lymphoma
      3. Multiple Myeloma
      4. Autoimmune Disorders
      5. Others
    4. CAR-T Cell Therapy Market Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
      1. Hospitals
      2. Cancer Care Treatment Centres
      3. Academic & Research Institutes
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Product 2022-2034 (USD MILLION/ Units)
        1. Abecma
        2. Breyanzi
        3. Kymriah
        4. Tecartus
        5. Yescarta
        6. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Leukemia
        2. Lymphoma
        3. Multiple Myeloma
        4. Autoimmune Disorders
        5. Others
      4. Market Size & Forecast By End User 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Cancer Care Treatment Centres
        3. Academic & Research Institutes
  12. Competitive Landscape
    1. CAR-T Cell Therapy Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Novartis (Switzerland)
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences / Kite Pharma (US)
    3. Bristol Myers Squibb (US)
    4. Johnson & Johnson Innovative Medicine (US)
    5. Legend Biotech (US)
    6. JW Therapeutics (China)
    7. Autolus Therapeutics (UK)
    8. Allogene Therapeutics (US)
    9. Cellectis (France)
    10. Bluebird Bio (US)
    11. Regeneron Pharmaceuticals (US)
    12. Precigen (US)
    13. Poseida Therapeutics (US)
    14. Miltenyi Biomedicine (Germany)
    15. Arcellx (US)
    16. ImmunoACT (India)
    17. Cartesian Therapeutics (US)
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global CAR-T Cell Therapy Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 3: Global CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 4: Global CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 5: North America CAR-T Cell Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 7: North America CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 8: North America CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 9: U.S. CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 10: U.S. CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 11: U.S. CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 12: Canada CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 13: Canada CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 14: Canada CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 15: Europe CAR-T Cell Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 17: Europe CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 18: Europe CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 19: U.K. CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 20: U.K. CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 21: U.K. CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 22: Germany CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 23: Germany CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 24: Germany CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 25: France CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 26: France CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 27: France CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 28: Spain CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 29: Spain CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 30: Spain CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 31: Italy CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 32: Italy CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 33: Italy CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 34: Russia CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 35: Russia CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 36: Russia CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 37: Nordic CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 38: Nordic CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 39: Nordic CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 40: Benelux CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 41: Benelux CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 42: Benelux CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 43: Rest of Europe CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 44: Rest of Europe CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 45: Rest of Europe CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 46: APAC CAR-T Cell Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 48: APAC CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 49: APAC CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 50: China CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 51: China CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 52: China CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 53: Korea CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 54: Korea CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 55: Korea CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 56: Japan CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 57: Japan CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 58: Japan CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 59: India CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 60: India CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 61: India CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 62: Australia CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 63: Australia CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 64: Australia CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 65: Taiwan CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 66: Taiwan CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 67: Taiwan CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 68: South East Asia CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 69: South East Asia CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 70: South East Asia CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 74: Middle East and Africa CAR-T Cell Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 76: Middle East and Africa CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 77: Middle East and Africa CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 78: UAE CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 79: UAE CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 80: UAE CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 81: Turkey CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 82: Turkey CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 83: Turkey CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 84: Saudi Arabia CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 85: Saudi Arabia CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 86: Saudi Arabia CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 87: South Africa CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 88: South Africa CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 89: South Africa CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 90: Egypt CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 91: Egypt CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 92: Egypt CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 93: Nigeria CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 94: Nigeria CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 95: Nigeria CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 96: Rest of MEA CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 97: Rest of MEA CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 98: Rest of MEA CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 99: LATAM CAR-T Cell Therapy Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 101: LATAM CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 102: LATAM CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 103: Brazil CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 104: Brazil CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 105: Brazil CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 106: Mexico CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 107: Mexico CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 108: Mexico CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 109: Argentina CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 110: Argentina CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 111: Argentina CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 112: Chile CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 113: Chile CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 114: Chile CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 115: Colombia CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 116: Colombia CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 117: Colombia CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

Table 118: Rest of LATAM CAR-T Cell Therapy Market Size and Forecast By Product - 2022-2034 (USD Billion)

Table 119: Rest of LATAM CAR-T Cell Therapy Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 120: Rest of LATAM CAR-T Cell Therapy Market Size and Forecast By End User - 2022-2034 (USD Billion)

We are featured on: